World Intellectual Property Organization

The World Intellectual Property Organization (WIPO) has published clinical-stage biopharma Tryp Therapeutics Inc. (OTCQB: TRYPF)’s international patent application for the intravenous (IV) administration of psilocybin and psilocin.  The “Improved Methods For The Use of Psychedelics...

Mydecine (OTC: MYCOF) and Lobe Sciences (OTCQB: LOBEF), two companies in the psychedelics space, have filed patent applications. This is the first step in the process of receiving a patent, which needs to be granted by an overseeing body. Mydecine's Patent On The MYCO-006 Family Of Compounds...

Numinus Wellness Inc. (OTCQX: NUMIF) sent a patent application to the World Intellectual Property Organization (WIPO) through its subsidiary, Numinus Bioscience Inc., for a prompt production process for Psilocybe and other fungi species containing psilocybin and variant compounds. WIPO is the...

Cybin Inc. (NYSE: CYBN) announced that the World Intellectual Property Organization (WIPO) published an international patent application covering a range of inhalation delivery methods for psychedelic molecules. “Our progress to secure IP for unique psychedelic delivery methods strongly...